Pharma News

CAMBRIDGE, Mass. - Editas Medicine, Inc., whose stock has surged over 260% in the past six months according to InvestingPro data

China-based companies are responsible for 20% of drugs in development globally, reflecting the powerhouse role the country has embraced in the pharmaceutical industry.

Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy

AstraZeneca and Daiichi’s Datroway trumps chemo in first-line breast cancer

McMaster University and MIT discover new antibiotic for IBD

Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB)

IGC Pharma's Preclinical Data for IGC-1C: New Drug Candidate Potentially Disrupts a Foundational Mechanism of Alzheimer's Disease

Engineered IL-21 cytokine mimic enhances antitumour immunity in preclinical models

FDA announced a new pilot program designed to provide faster reviews for domestically tested and manufactured generic drugs.

Rocket ditches blood disorder gene therapy in ongoing pipeline pivot

AAVantgarde Announces FDA Orphan Drug Designation and UK CTA approval for AAVB-039 for the Treatment of Stargardt Disease

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting